• S&P 500: 1,342.64
  • Change: -0.69%
$14.10 0.62 (+4.60%)
2/10/2012 4:00 PM

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

CAPS Rating: 4 out of 5

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

View All Commentary (SPPI)

Recs

0
Player Avatar Bhavtrader (< 20) Submitted: 9/26/2009 9:04:36 AM : Outperform Start Price: $6.55 SPPI Score: +87.12

good pipeline, Coming FDA approval, no debt, 158 million in cash, possible buy-out

Report this Post Add Comment

Featured Broker Partners